Baker Hughes Forecast, price target & analysts
Baker Hughes Target price 2025 - Analyst rating & recommendation
Baker Hughes Classifications & Recommendation:
Baker Hughes Price Target
| Target Price | $50.09 |
| Price | $38.16 |
| Potential | 31.27% |
| Number of Estimates | 22 |
| 22 Analysts have issued a price target Baker Hughes 2026 . The average Baker Hughes target price is $50.09. This is 31.27% higher than the current stock price. The highest price target is $58.00 51.99% , the lowest is $40.00 4.82% . | |
| A rating was issued by 28 analysts: 23 Analysts recommend Baker Hughes to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Baker Hughes stock has an average upside potential 2026 of 31.27% . Most analysts recommend the Baker Hughes stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2029
21 Analysts have issued a sales forecast Baker Hughes 2025 . The average Baker Hughes sales estimate is $27.7b . This is 0.55% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $28.3b 1.84% , the lowest is $27.2b 2.40% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $27.8b | 9.11% |
|---|---|---|
| 2025 | $27.7b | 0.55% |
| 2026 | $28.6b | 3.45% |
| 2027 | $29.2b | 2.10% |
| 2028 | $29.1b | 0.52% |
| 2029 | $27.7b | 4.82% |
22 Analysts have issued an Baker Hughes EBITDA forecast 2025. The average Baker Hughes EBITDA estimate is $4.9b . This is 8.21% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.1b 12.13% , the lowest is $4.6b 2.88% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $4.5b | 21.22% |
|---|---|---|
| 2025 | $4.9b | 8.21% |
| 2026 | $5.3b | 9.04% |
| 2027 | $5.6b | 5.35% |
| 2028 | $5.7b | 0.91% |
| 2029 | $5.3b | 7.26% |
EBITDA Margin
| 2024 | 16.23% | 11.10% |
|---|---|---|
| 2025 | 17.66% | 8.78% |
| 2026 | 18.62% | 5.44% |
| 2027 | 19.21% | 3.17% |
| 2028 | 19.49% | 1.46% |
| 2029 | 18.99% | 2.57% |
10 Baker Hughes Analysts have issued a net profit forecast 2025. The average Baker Hughes net profit estimate is $2.5b . This is 13.88% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.6b 10.40% , the lowest is $2.4b 17.45% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $2.9b | 56.02% |
|---|---|---|
| 2025 | $2.5b | 13.88% |
| 2026 | $2.9b | 14.02% |
| 2027 | $3.2b | 10.13% |
Net Margin
| 2024 | 10.60% | 43.00% |
|---|---|---|
| 2025 | 9.18% | 13.38% |
| 2026 | 10.12% | 10.24% |
| 2027 | 10.91% | 7.81% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
10 Analysts have issued a Baker Hughes forecast for earnings per share. The average Baker Hughes EPS is $2.57 . This is 13.76% lower than earnings per share in the financial year 2024. The highest EPS forecast is $2.67 10.40% , the lowest is $2.46 17.45% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $2.98 | 56.02% |
|---|---|---|
| 2025 | $2.57 | 13.76% |
| 2026 | $2.93 | 14.01% |
| 2027 | $3.22 | 9.90% |
P/E ratio
| Current | 12.81 | 25.83% |
|---|---|---|
| 2025 | 14.87 | 16.08% |
| 2026 | 13.04 | 12.31% |
| 2027 | 11.84 | 9.20% |
Based on analysts' sales estimates for 2025, the Baker Hughes stock is valued at an EV/Sales of 1.45 and an P/S ratio of 1.37 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 1.44 | 1.41% |
|---|---|---|
| 2025 | 1.45 | 0.37% |
| 2026 | 1.40 | 3.33% |
| 2027 | 1.37 | 2.05% |
| 2028 | 1.38 | 0.53% |
| 2029 | 1.45 | 5.06% |
P/S ratio
| Current | 1.36 | 4.71% |
|---|---|---|
| 2025 | 1.37 | 0.55% |
| 2026 | 1.32 | 3.33% |
| 2027 | 1.29 | 2.05% |
| 2028 | 1.30 | 0.52% |
| 2029 | 1.37 | 5.06% |
Current Baker Hughes Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Stifel |
Buy
➜
Buy
|
Unchanged | Apr 15 2025 |
| Susquehanna |
Positive
➜
Positive
|
Unchanged | Apr 14 2025 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Apr 08 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Mar 31 2025 |
| Benchmark |
Buy
➜
Buy
|
Unchanged | Feb 11 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Feb 04 2025 |
| Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Feb 03 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Stifel:
Buy
➜
Buy
|
Apr 15 2025 |
|
Unchanged
Susquehanna:
Positive
➜
Positive
|
Apr 14 2025 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Apr 08 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Mar 31 2025 |
|
Unchanged
Benchmark:
Buy
➜
Buy
|
Feb 11 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Feb 04 2025 |
|
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Feb 03 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
